DNASTAR
| Privately held company | |
| Industry | Bioinformatics Software |
| Founders |
|
| Headquarters | Madison, Wisconsin, United States |
Area served | Worldwide |
| Products | Software |
| Website | DNASTAR |
DNASTAR is a global bioinformatics software company incorporated in 1984 that is headquartered in Madison, Wisconsin. DNASTAR develops and sells software for sequence analysis in the fields of genomics and molecular biology.
Software
DNASTAR software (Lasergene) first gained popularity in the 1980s and 1990s for its sequence assembly and analysis capabilities of Sanger sequencing data. Lasergene 12.2 was released in February 2015.[1] DNASTAR software is available for desktop computers running Mac OS X, Windows, and Linux as well as for use on Amazon Web Services.
In 2007, DNASTAR expanded their offerings to include software for next-generation sequencing and structural biology.[2] DNASTAR's next-gen software supports data from Illumina, Ion Torrent, Pacific Biosciences, and Roche 454 and allows the user to assemble, align, analyze and visualize genomic data. Lasergene's use in next-generation sequence assembly and analysis was contributed as a chapter, written by company scientists, to the 2008 book Next Generation Genome Sequencing edited by Michael Janitz.[3]
DNASTAR software is utilized by pharmaceutical, biotechnology, academic, and clinical researchers in more than 90 countries.[4]
Reviews
Writing in The Scientist, David R. Smith gave positive reviews to several bioinformatics software packages including DNAstar, but said that his bioinformatics skills plateaued and the licensing and upgrading costs were a significant proportion of his lab's operating budget.[5]
Accolades
In 2007, DNASTAR was awarded a Reader's Choice Gold Award by Scientific Computing Magazine for the Lasergene sequence analysis software.[6]
The 2008 book Inventing Entrepreneurs: Technology Innovators and their Entrepreneurial Journey by Gerard George and Adam J. Bock includes DNASTAR as an example of an innovative and entrepreneurial success story.[7]
A research study by BMC Genomics in 2010 determined that SeqMan (DNASTAR's next-gen sequence assembly application) assemblies performed best, with more novel sequences and better recapitulation of transcripts.[8]
Another BMC Genomics study in 2011 determined that the best overall contig performance resulted from a SeqMan NGen assembly.[9]
Customers
External links
See also
References
- ↑ Schwei, Tom (6 February 2015). "DNASTAR Lasergene 12.2 Software Achieves High Accuracy" (Press release). DNASTAR.
- ↑ "Company Profile". DNASTAR. Retrieved 25 October 2014.
- ↑ Janitz, Michael (November 2008). Next-Generation Genome Sequencing: Towards Personalized Medicine. Wiley-VCH. ISBN 978-3-527-32090-5.
- ↑ "DNASTAR Careers". DNASTAR. Retrieved 25 October 2014.
- ↑ The Scientist, September 2 2014 http://www.the-scientist.com/?articles.view/articleNo/40916/title/Opinion--Bioinformatics-Software--A-Buyer-s-Guide/
- ↑ Staff (30 June 2007). "Bioinformatics Readers' Choice — Gold Award: Lasergene". Product Releases. Scientific Computing. Advantage Business Media.
- ↑ Gerry, George; Bock, Adam (January 2008). Inventing Entrepreneurs: Technology Innovators and their Entrepreneurial Journey. Prentice Hall. ISBN 978-0-13-157470-0.
- ↑ Kumar, Sujai; Blaxter, Mark L. (16 October 2010). "Comparing ‘’de novo’’ assemblers for 454 transcriptome data". BMC Genomics 11. doi:10.1186/1471-2164-11-571. 571.
- ↑ Feldmeyer, Barbara; Wheat, Christopher W.; et al. (16 June 2011). "Short read Illumina data for the ‘’de novo’’ assembly of a non-model snail species transcriptome (‘’Radix balthica’’, Basommatophora, Pulmonata), and a comparison of assembler performance". BMC Genomics 12. doi:10.1186/1471-2164-12-317. 317.
- ↑ Staff (1 January 2014). "Products & Services Deals". Gen. Eng. Biotechnol. News (paper) 34 (1). p. 11.
...entered into a multiyear software license agreement with DNAStar for the use of Lasergene software as its primary sequence assembly and analysis software platform for researchers within its organization.